PTK 787

vatalanib · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTK 787, covering 2012-01-20 to 2012-01-20. Get the full timeline:

Most recent: Clinical Trial Update: PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP [Phase 1, Phase 2]